METHODS FOR USING ANTAGONISTIC ANTI-AVB3 INTEGRIN ANTIBODIES
摘要
<p>Monoclonal antibodies that recognize the αvβ3 integrin receptor complex, but do not significantly bind to αIIbβIIIa, can be used in methods for treating αvβ3 integrin-mediated diseases, such as tumor metastasis.</p>
